InterviewSolution
Saved Bookmarks
| 1. |
Tata Capital Growth Fund plans to acquire how much percent of stake in Biocon Biologics India for 30 Million USD? |
| Answer» On 31st July 2020, Biocon Biologics India approved the primary equity investment of around Rs.225 crore (30 Million USD) by Tata Capital Growth Fund for a 0.85% minority stake in Biocon Biologics, biosimilar business, at an equity valuation of around Rs. 26,250 crore (3.5 billion USD) and enterprise valuation of around Rs. 30,400 crore (4 billion USD). | |